You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1123)
- Medicine safety (503)
- Medical devices safety (345)
- Shortages (78)
- Safety (57)
- Prescription medicines (48)
- Regulatory compliance (20)
- Import and export (16)
- Listed medicines (14)
- Over the counter (OTC) medicines (13)
- Therapeutic goods regulation (13)
- Complementary medicines (10)
- Australian Register of Therapeutic Goods (ARTG) (8)
- Blood safety (8)
- Non-prescription medicines (6)
- Advertising (3)
- Sunscreens (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Type of content
Results for
"[search-keyword]"
Search
1328 result(s) found, displaying 126 to 150
-
Safety alertsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
-
Safety alertsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
-
Safety alertsA safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.
-
Medicine shortage alertsWe continue to monitor antibiotic medicines in shortage and are seeking and prioritising applications for overseas alternatives to assist with supply.
-
Recall actionsMedtronic Australasia is informing customers about the serious risk of valve infolding for EvolutePRO+ 34mm Transcatheter Aortic Valve (TAV), item code - EVPROPLUS-34US.
-
Medicine shortage alertsTo help manage the shortage of the antibiotic phenoxymethylpenicillin (Penicillin V), we have made a Serious Scarcity Substitution Instrument (SSSI).
-
Recall actionsBioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.
-
Medicine shortage alertsThe Metalyse (tenecteplase) shortage is now resolved.
-
Medicine shortage alertsAs the shortage of Coumadin 5mg tablets is expected to continue, the TGA has made a Serious Scarcity Substitution Instrument to assist patients to access their medicine from their pharmacist without delay or interruption to treatment.
-
Medicine shortage alertsThe TGA is aware of several warfarin product shortages due to manufacturing issues.
-
Recall actionsThe TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.
-
Recall actionsUsers may experience extended periods of signal loss and during this time they won’t receive high or low glucose alarms.
-
Recall actionsChurch and Dwight are recalling two batches of Curash Nappy Rash Cream, following reports of adverse reactions
-
Recall actionsPhilips has advised that corrected pads will be shipped in early 2023 to customers affected by the problem.
-
Medicine shortage alertsThe shortages list of antibiotics has been updated.
-
-
Safety alertsRead updated information on nitrosamine impurities, the TGA response and requirements for medicine sponsors and manufacturers.
-
Medicine shortage alertsA reminder for health professionals and consumers on safe and equitable dispensing and supply
-
Recall actionsRecall of API Forearm crutches - tall and adult sizes
-
Safety alertsPhilips Respironics (the manufacturer) detected two problems with corrected Trilogy 100 ventilators
-
Recall actionsZimmer Biomet, in consultation with the TGA, is issuing an Implant Hazard Alert for the NexGen Stemmed Cemented Option Tibial Component.
-
Medicine shortage alertsTo assist with timely access for patients using cefalexin, the TGA has made a Serious Scarcity Substitution Instrument (SSSI).
-
Medicine shortage alertsThe SSSI for isosorbide mononitrate 120mg modified release tablets is extended to 30 June 2023.
-
Safety alertsSafety advisory - Compatibility of tubing connectors and medical gas sources
-
Safety alertsSafety advisory - contamination of quinapril medicines with low levels of nitrosamine impurity